Sitaphage 50/500 mg Tablets (Sitagliptin + Metformin HCl)
₨ 473
Sitaphage (Sitagliptin + Metformin HCl) 50mg/500mg Tablets – Martin Dow
Sitaphage combines Sitagliptin and Metformin Hydrochloride to help control blood glucose levels in patients with Type 2 Diabetes Mellitus.
Sitagliptin enhances insulin release, while Metformin reduces glucose production in the liver, offering dual action for effective glycemic control.
Manufacturer: Martin Dow
Strength: 50mg Sitagliptin + 500mg Metformin HCl
Packing: 14 Film-Coated Tablets
Description
Brand Name: Sitaphage
Generic Name: Sitagliptin + Metformin Hydrochloride
Dosage Strength: 50mg Sitagliptin + 500mg Metformin HCl
Manufacturer: Martin Dow
Packing: 14 Film-Coated Tablets
Sitaphage Description and Usage:
Sitaphage 50/500mg is an oral antidiabetic combination medicine used for managing type 2 diabetes mellitus. It blends two complementary agents that help control blood sugar levels more effectively.
Sitagliptin, a DPP-4 (dipeptidyl peptidase-4) inhibitor, enhances insulin secretion and decreases glucose production by the liver, especially after meals.
Metformin Hydrochloride, a biguanide, improves insulin sensitivity, lowers hepatic glucose output, and increases glucose uptake in muscle tissues.
Sitaphage is prescribed for adults whose blood sugar levels are inadequately managed by diet, exercise, or Metformin alone. Regular use helps achieve better glycemic control and reduces long-term diabetes complications.
Disclaimer
The image shown is for illustrative purposes only and may differ from the actual product.
This medication should only be used under medical supervision.
Not for self-medication. Always consult your oncologist or healthcare provider before use.
Gileaz.com does not provide medical advice or prescriptions.
Product availability and price may vary based on stock and regional regulations.
Only logged in customers who have purchased this product may leave a review.











Reviews
There are no reviews yet.